1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Oncology Biopharmaceuticals Market
2.2. Global Oncology Biopharmaceuticals Market, By Product Type, 2024 (US$ Million)
2.3. Global Oncology Biopharmaceuticals Market, By Cancer Type, 2024 (US$ Million)
2.4. Global Oncology Biopharmaceuticals Market, By Route of Administration, 2024 (US$ Million)
2.5. Global Oncology Biopharmaceuticals Market, By Drug Type, 2024 (US$ Million)
2.6. Global Oncology Biopharmaceuticals Market, By Distribution channel, 2024 (US$ Million)
2.7. Global Oncology Biopharmaceuticals Market, By Geography, 2024 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2024

3. Oncology Biopharmaceuticals Market: Competitive Analysis
3.1. Market Positioning of Key Oncology Biopharmaceuticals Market Vendors
3.2. Strategies Adopted by Oncology Biopharmaceuticals Market Vendors

4. Oncology Biopharmaceuticals Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Oncology Biopharmaceuticals Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape

5. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Monoclonal antibodies
5.3.2. Immune checkpoint inhibitors
5.3.3. Cell and gene therapies
5.3.4. Antibody-drug conjugates (ADCs)
5.3.5. Cancer vaccines
5.3.6. Other product types  

6. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Lung Cancer
6.3.2. Breast Cancer
6.3.3. Colorectal Cancer
6.3.4. Prostate Cancer
6.3.5. Leukemia and Lymphoma
6.3.6. Melanoma
6.3.7. Ovarian and Cervical Cancer
6.3.8. Other Cancer types

7. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2024 Versus 2033
7.3. Market Segmentation
7.3.1. Oral
7.3.2. Parenteral
7.3.3. Other route of administration

8. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2024 Versus 2033
8.3. Market Segmentation
8.3.1. Proprietary (Branded)
8.3.2. Biosimilars

9. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2024 Versus 2033
9.3. Market Segmentation
9.3.1. Hospital pharmacies
9.3.2. Drug stores and retail pharmacies
9.3.3. Online pharmacies


10. North America Oncology Biopharmaceuticals Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
10.3. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
10.4. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
10.5. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
10.6. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
10.7.Oncology Biopharmaceuticals Market: By Region, 2023-2033, USD (Million)
10.7.1.North America
10.7.1.1. U.S.
10.7.1.1.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
10.7.1.1.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
10.7.1.1.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
10.7.1.1.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
10.7.1.1.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
10.7.1.2.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
10.7.1.2.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
10.7.1.2.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
10.7.1.2.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
10.7.1.3.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
10.7.1.3.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
10.7.1.3.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
10.7.1.3.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)

11. UK and European Union Oncology Biopharmaceuticals Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
11.3. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
11.4. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
11.5. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
11.6. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
11.7.Oncology Biopharmaceuticals Market: By Region, 2023-2033, USD (Million)
11.7.1.UK and European Union
11.7.1.1. UK
11.7.1.1.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
11.7.1.1.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
11.7.1.1.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
11.7.1.1.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
11.7.1.1.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
11.7.1.2.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
11.7.1.2.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
11.7.1.2.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
11.7.1.2.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
11.7.1.3.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
11.7.1.3.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
11.7.1.3.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
11.7.1.3.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
11.7.1.4.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
11.7.1.4.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
11.7.1.4.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
11.7.1.4.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
11.7.1.5. France
11.7.1.5.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
11.7.1.5.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
11.7.1.5.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
11.7.1.5.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
11.7.1.5.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
11.7.1.6.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
11.7.1.6.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
11.7.1.6.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
11.7.1.6.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)

12. Asia Pacific Oncology Biopharmaceuticals Market, 2023-2033, USD (Million)
12.1. Market Overview
12.2. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
12.3. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
12.4. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
12.5. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
12.6. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
12.7.Oncology Biopharmaceuticals Market: By Region, 2023-2033, USD (Million)
12.7.1.Asia Pacific
12.7.1.1. China
12.7.1.1.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
12.7.1.1.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
12.7.1.1.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
12.7.1.1.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
12.7.1.1.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
12.7.1.2.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
12.7.1.2.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
12.7.1.2.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
12.7.1.2.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
12.7.1.3. India
12.7.1.3.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
12.7.1.3.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
12.7.1.3.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
12.7.1.3.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
12.7.1.3.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
12.7.1.4.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
12.7.1.4.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
12.7.1.4.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
12.7.1.4.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
12.7.1.5.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
12.7.1.5.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
12.7.1.5.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
12.7.1.5.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
12.7.1.6.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
12.7.1.6.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
12.7.1.6.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
12.7.1.6.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)

13. Latin America Oncology Biopharmaceuticals Market, 2023-2033, USD (Million)
13.1. Market Overview
13.2. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
13.3. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
13.4. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
13.5. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
13.6. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
13.7.Oncology Biopharmaceuticals Market: By Region, 2023-2033, USD (Million)
13.7.1.Latin America
13.7.1.1. Brazil
13.7.1.1.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
13.7.1.1.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
13.7.1.1.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
13.7.1.1.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
13.7.1.1.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
13.7.1.2.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
13.7.1.2.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
13.7.1.2.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
13.7.1.2.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
13.7.1.3.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
13.7.1.3.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
13.7.1.3.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
13.7.1.3.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)

14. Middle East and Africa Oncology Biopharmaceuticals Market, 2023-2033, USD (Million)
14.1. Market Overview
14.2. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
14.3. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
14.4. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
14.5. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
14.6. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
14.7.Oncology Biopharmaceuticals Market: By Region, 2023-2033, USD (Million)
14.7.1.Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
14.7.1.1.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
14.7.1.1.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
14.7.1.1.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
14.7.1.1.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
14.7.1.2.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
14.7.1.2.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
14.7.1.2.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
14.7.1.2.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. Oncology Biopharmaceuticals Market: By Product Type, 2023-2033, USD (Million)
14.7.1.3.2. Oncology Biopharmaceuticals Market: By Cancer Type, 2023-2033, USD (Million)
14.7.1.3.3. Oncology Biopharmaceuticals Market: By Route of Administration, 2023-2033, USD (Million)
14.7.1.3.4. Oncology Biopharmaceuticals Market: By Drug Type, 2023-2033, USD (Million)
14.7.1.3.5. Oncology Biopharmaceuticals Market: By Distribution channel, 2023-2033, USD (Million)

15. Company Profile
15.1. AbbVie (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
15.2. Amgen
15.3. AstraZeneca
15.4. Bayer
15.5. Biogen
15.6. Bristol-Myers Squibb
15.7. Eli Lilly
15.8. F. Hoffmann-La Roche
15.9. GlaxoSmithKline
15.10. Johnson & Johnson
15.11. Merck
15.12. Novartis
15.13. Pfizer
15.14. Sanofi
15.15. Takeda Pharmaceutical
15.16. Sandoz
15.17. Biocon
15.18. Celltrion
15.19. Adaptimmune
15.20. Legend Biotech
15.21. Other Notable Players